NNVC Nanoviricides
- 1.680
- +0.280+20.00%
- 1.790
- +0.110+6.55%
Nanoviricides News
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | 3: Initial statement of beneficial ownership of securities
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | 3: Initial statement of beneficial ownership of securities
Nanoviricides | D: Filing D
Nanoviricides | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
